Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tetsusuke, Yoshimoto"'
Publikováno v:
BMC Palliative Care, Vol 17, Iss 1, Pp 1-7 (2018)
Abstract Background The Pain Management Index (PMI) is widely used in the assessment of pain management, and negative scores are traditionally considered to indicate inadequate pain management. However, it is not known whether negative PMI scores are
Externí odkaz:
https://doaj.org/article/85efa317dab04f419e727b9831edb634
Publikováno v:
Biological and Pharmaceutical Bulletin. 41:850-857
Pure oxycodone injection became increasingly necessary after oral oxycodone was launched in Japan in 2003. However, trials clarifying the efficacy and safety of injection are rare. Therefore, a multicenter open study on injection was designed and car
Autor:
Kazumi Hasegawa, Tetsusuke Yoshimoto, Yayoi Mizumoto, Kumi Gouji, Kenro Sawada, Naomi Kumazawa
Publikováno v:
Palliative Care Research. 12:565-569
Autor:
Shiro Tomiyasu, Tomohiro Tamaki, Toshinari Saeki, Masahiko Murakami, Motohiro Matoba, Takahiro Hashizume, Tetsusuke Yoshimoto
Publikováno v:
American Journal of Hospice and Palliative Medicine®. 34:92-99
It has been reported that pain relief for patients with cancer is suboptimal in Japan. This has been mainly attributed to inadequate dissemination of the World Health Organization (WHO) guidelines for cancer pain management. To better understand this
Publikováno v:
BMC Palliative Care
BMC Palliative Care, Vol 17, Iss 1, Pp 1-7 (2018)
BMC Palliative Care, Vol 17, Iss 1, Pp 1-7 (2018)
Background The Pain Management Index (PMI) is widely used in the assessment of pain management, and negative scores are traditionally considered to indicate inadequate pain management. However, it is not known whether negative PMI scores are always p
Autor:
Momoko Iwamoto, Hiroki Miura, Shigeyuki Tanaka, Takahiro Kawaguchi, Motohiro Matoba, Shigeaki Yoshida, Itsuku Yamashita, Tetsusuke Yoshimoto, Takahiro Higashi
Publikováno v:
Japanese Journal of Clinical Oncology. 45:1036-1041
Objective The state of opioid consumption among cancer patients has never been comprehensively investigated in Japan. The Diagnosis Procedure Combination claims data may be used to measure and monitor opioid consumption among cancer patients, but the
Autor:
Tsutomu Suzuki, Tomohiro Tamaki, Motohiro Matoba, Kinomi Yomiya, Shiro Tomiyasu, Tetsusuke Yoshimoto, Naoki Matsuo
Publikováno v:
American Journal of Hospice and Palliative Medicine®. 26:112-118
Purpose: Baclofen is a g-aminobutyric acid receptor agonist commonly used for managing many types of neuropathic pain. The effect of baclofen on cancer pain has not previously been studied. This retrospective study evaluated the efficacy of baclofen
Autor:
Shigeru Tanda, Kinomi Yomiya, Kenji Eguchi, Isamu Adachi, Motohiro Matoba, Yasuo Shima, Chizuko Takigawa, Tetsusuke Yoshimoto, Fumio Goto
Publikováno v:
Japanese Journal of Clinical Oncology
Objective Rapid analgesic onset opioids, particularly fentanyl buccal tablet, is preferable for managing breakthrough pain. The efficacy and safety of fentanyl buccal tablet and its association with around-the-clock opioids needs to be explored with
Publikováno v:
Journal of painpalliative care pharmacotherapy. 28(4)
In Japan, Oxycodone hydrochloride injection formulation has been approved in 2012. However, its pharmacokinetics has been poorly studied. The aim of this study is to evaluate the pharmacokinetics of oxycodone after intravenous and subcutaneous admini
Autor:
Kinomi Yomiya, Shigeru Tanda, Tetsusuke Yoshimoto, Isamu Adachi, Chizuko Takigawa, Hiroshi Kunikane, Motohiro Matoba, Katsunori Shinozaki, Yasuo Shima, Sasagu Hamada, Kenji Eguchi, Toshifumi Kosugi, Fumio Goto
Publikováno v:
Journal of pain and symptom management. 47(6)
Context Rapid-onset opioids for treating breakthrough pain (BTP) in patients with cancer are needed in the Japanese care setting. Objectives To examine the efficacy and safety of fentanyl buccal tablets (FBTs) for treating BTP in Japanese cancer pati